![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12â15 June 2019 - ()] Poster Presentations - THU0353â AN ORALLY AVAILABLE HIGHLY SELECTIVE 5-HYDROXYTRYPTAMINE 2B (5-HT2B) RECEPTOR ANTAGONIST AMELIORATING PULMONARY AND DERMAL FIBROSIS IN PRECLINICAL MODELS OF SYSTEMIC SCLEROSIS
Wenglén, Christina, Arozenius, Helena, Pettersson, Lars, Ekstrom, GunillaYear:
2019
DOI:
10.1136/annrheumdis-2019-eular.6808
File:
PDF, 467 KB
2019